523 related articles for article (PubMed ID: 34811504)
21. The Role of Liquid Biopsies in Pediatric Brain Tumors.
Tang K; Gardner S; Snuderl M
J Neuropathol Exp Neurol; 2020 Sep; 79(9):934-940. PubMed ID: 32766689
[TBL] [Abstract][Full Text] [Related]
22. Cell-free DNA analysis in current cancer clinical trials: a review.
Cisneros-Villanueva M; Hidalgo-Pérez L; Rios-Romero M; Cedro-Tanda A; Ruiz-Villavicencio CA; Page K; Hastings R; Fernandez-Garcia D; Allsopp R; Fonseca-Montaño MA; Jimenez-Morales S; Padilla-Palma V; Shaw JA; Hidalgo-Miranda A
Br J Cancer; 2022 Feb; 126(3):391-400. PubMed ID: 35027672
[TBL] [Abstract][Full Text] [Related]
23. Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles.
Corvigno S; Johnson AM; Wong KK; Cho MS; Afshar-Kharghan V; Menter DG; Sood AK
Mol Cancer Ther; 2022 Jul; 21(7):1067-1075. PubMed ID: 35545008
[TBL] [Abstract][Full Text] [Related]
24. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.
Geeurickx E; Hendrix A
Mol Aspects Med; 2020 Apr; 72():100828. PubMed ID: 31711714
[TBL] [Abstract][Full Text] [Related]
25. [Innovations in personalized medicine : Molecular characterization of liquid biopsy-fake or fact?].
Theil G; Fornara P
Urologe A; 2018 Sep; 57(9):1069-1074. PubMed ID: 29971453
[TBL] [Abstract][Full Text] [Related]
26. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
27. Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.
Heestermans R; Schots R; De Becker A; Van Riet I
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791247
[TBL] [Abstract][Full Text] [Related]
28. Liquid Biopsy in Prostate Cancer: Circulating Tumor Cells and Beyond.
Zainfeld D; Goldkorn A
Cancer Treat Res; 2018; 175():87-104. PubMed ID: 30168118
[TBL] [Abstract][Full Text] [Related]
29. Comparative application of microfluidic systems in circulating tumor cells and extracellular vesicles isolation; a review.
Adriani RR; Gargari SLM
Biomed Microdevices; 2022 Dec; 25(1):4. PubMed ID: 36574057
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
[No Abstract] [Full Text] [Related]
31. Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts?
Słomka A; Wang B; Mocan T; Horhat A; Willms AG; Schmidt-Wolf IGH; Strassburg CP; Gonzalez-Carmona MA; Lukacs-Kornek V; Kornek MT
Theranostics; 2022; 12(13):5836-5855. PubMed ID: 35966579
[TBL] [Abstract][Full Text] [Related]
32. A review of sensors for classification and subtype discrimination of cancer: Insights into circulating tumor cells and tumor-derived extracellular vesicles.
He S; Ding L; Yuan H; Zhao G; Yang X; Wu Y
Anal Chim Acta; 2023 Mar; 1244():340703. PubMed ID: 36737145
[TBL] [Abstract][Full Text] [Related]
33. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H
Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643
[TBL] [Abstract][Full Text] [Related]
34. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B
Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514
[TBL] [Abstract][Full Text] [Related]
35. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
36. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
Morrison GJ; Goldkorn A
Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
[TBL] [Abstract][Full Text] [Related]
37. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.
Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y
Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111
[TBL] [Abstract][Full Text] [Related]
38. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.
Mishra V; Singh A; Chen X; Rosenberg AJ; Pearson AT; Zhavoronkov A; Savage PA; Lingen MW; Agrawal N; Izumchenko E
Br J Cancer; 2022 Feb; 126(3):361-370. PubMed ID: 34876674
[TBL] [Abstract][Full Text] [Related]
39. Circulating RNAs in prostate cancer patients.
Mugoni V; Ciani Y; Nardella C; Demichelis F
Cancer Lett; 2022 Jan; 524():57-69. PubMed ID: 34656688
[TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy technologies based on membrane microfluidics: High-yield purification and selective quantification of biomarkers in nanocarriers.
Wang C; Senapati S; Chang HC
Electrophoresis; 2020 Nov; 41(21-22):1878-1892. PubMed ID: 32180242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
